Edgewise Therapeutics (EWTX) Earnings Date & Reports
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EWTX is expected to report earnings to fall 3.28% to -41 cents per share on August 07
Q2'25
Est.
$-0.42
Q1'25
Est.
$-0.43
Q4'24
Est.
$-0.42
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.34
The last earnings report on May 08 showed earnings per share of -43 cents, meeting the estimate of -43 cents. With 1.01M shares outstanding, the current market capitalization sits at 1.49B.